Will Stereotaxis (AMEX:STXS) continue to fall in September?

STXS
 Stock
  

USD 1.75  0.15  7.89%   

As many millenniums are trying to avoid healthcare space, it makes sense to sum up Stereotaxis a little further and try to understand its current market patterns. As we have suggested previously, Stereotaxis is beginning its fall as retail investors shift to be more bearish due to the increased sector volatility. Stereotaxis hyperactively responds to market trends. Lots of the inclinations of the company stock price movements has been a rough manifestation of what is happening in the market overall. Invariable basic indicators of the enterprise may connote signs of short-term price drift for retail investors. Stereotaxis is scheduled to announce its earnings today.
Published over a month ago
View all stories for Stereotaxis | View All Stories
The company's average rating is Strong Buy from 4 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Stereotaxis market sentiment investors' perception of the future value of Stereotaxis. Let us look at a few aspects of Stereotaxis technical analysis. The company has Profit Margin (PM) of (39.69) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (46.21) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.46.
Using predictive technical analysis, we will analyze different prices and returns patterns and diagnose historical swings to determine the real value of Stereotaxis. In general, we focus on analyzing Stereotaxis stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Stereotaxis's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Stereotaxis's intrinsic value. In addition to deriving basic predictive indicators for Stereotaxis, we also check how macroeconomic factors affect Stereotaxis price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Stereotaxis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Stereotaxis in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Stereotaxis. Your research has to be compared to or analyzed against Stereotaxis' peers to derive any actionable benefits. When done correctly, Stereotaxis' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Stereotaxis.

How important is Stereotaxis's Liquidity

Stereotaxis financial leverage refers to using borrowed capital as a funding source to finance Stereotaxis ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Stereotaxis financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Stereotaxis's total debt and its cash.

How does Stereotaxis utilize its cash?

To perform a cash flow analysis of Stereotaxis, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Stereotaxis is receiving and how much cash it distributes out in a given period. The Stereotaxis cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.

Closer look at Stereotaxis Semi Deviation

Stereotaxis has current Semi Deviation of 4.6. Semi-deviation provides a good measure of downside risk for a equity or a portfolio. It is similar to standard deviation, but it only looks at periods where the returns are less than the target or average level.

Semi-deviation is the square root of semi-variance. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.

Semi Deviation 
=  
SQRT(SV) 
 = 
4.6
SQRT = Square root notation
SV =   Stereotaxis semi variance of returns over selected period

Will Stereotaxis retail investors go crazy after another fall?

The total risk alpha is down to 0.38 as of today.
As of the 9th of August, Stereotaxis has the Coefficient Of Variation of 2929.93, semi deviation of 4.6, and Risk Adjusted Performance of 0.0522. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Stereotaxis, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We have analyzed and interpolated nineteen technical drivers for Stereotaxis, which can be compared to its competition. Please validate Stereotaxis semi deviation, jensen alpha, as well as the relationship between the Jensen Alpha and semi variance to decide if Stereotaxis is priced more or less accurately, providing market reflects its prevalent price of 2.09 per share. Please also confirm Stereotaxis total risk alpha, which is currently at 0.3837 to double-check the company can sustain itself at a future point.

Our Conclusion on Stereotaxis

While many of the other players within the medical instruments & supplies industry are still a little expensive, even after the recent corrections, Stereotaxis may offer a potential longer-term growth to retail investors. Taking everything into account, as of the 9th of August 2022, our analysis shows that Stereotaxis hyperactively responds to market trends. The enterprise is undervalued and projects very high odds of distress for the next 2 years. Our concluding 90 days buy vs. sell advice on the enterprise is Cautious Hold.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Stereotaxis. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com